|
 Of 69 migraine sufferers treated at a large academic headache
practice and referred for behavioral therapy, just 57 percent got as
far as making an appointment with the behavioral practitioner,
researchers found.
The patients who ignored their doctor's recommendation cited time
limitations as the main barrier to treatment. Concerns about cost
and insurance coverage were also an issue. And some were skeptical
about whether the treatment would work; others worried about the
potential stigma of seeing a psychologist, the study team reports in
the journal Pain Medicine.
"I hope that the impact of this study will be that more physicians,
patients and payors will realize that these evidence-based
treatments are being underutilized and are having an effect on the
opioid epidemic," lead author Dr. Mia Minen, chief of headache
research at NYU Langone Medical Center in New York City, said in a
telephone interview.
One in seven people in the U.S. experience migraine headaches, but
they are most common in women and may afflict up to one in four
women aged 18 to 44.
The severe headache pain of migraines can be accompanied by
sensitivity to light and sound as well as blurred vision, nausea and
vomiting. These headaches can be disabling and result in missed work
and frequent doctor visits.
Opioids are still being prescribed as the first line of treatment
for migraines when evidence shows that behavioral therapy is more
effective and safer in treating migraines, Minen said.
"There should be more doctors initiating behavioral therapy and
fewer insurance restrictions and limitations placed on these
treatments to make them more accessible to patients so they can
pursue them," she added.
"I don't think that people realize that behavioral therapy alone can
result in a 50 percent reduction in headache days. It's not only
effective alone, but when combined with medications it can have a
synergistic effect."
For their study, Minen and her colleagues enrolled 234 patients with
migraines who came to the NYU Langone headache center from July 2016
to March 2017.
Of these, 69 were referred for behavioral migraine treatment with a
trained therapist, but Minen's team was only able to reach 53 of
them when they followed-up two to three months later. At that time,
30 patients had, at a minimum, taken the step of setting up an
appointment for behavioral migraine treatment.
[to top of second column] |
Apart from it's small size, the study is limited by the fact that
patients treated at an academic specialty headache practice might
not represent all migraine sufferers, the authors note.
Minen said that patients who had previously seen a psychologist for
any reason were more likely to actually begin behavioral therapy.
More than 80 percent of the patients had consulted with a primary
care physician for their headaches. Patients had also sought help
for their migraines in emergency rooms or with ophthalmologists.
"This suggests that patients perceived greater barriers to accessing
behavioral, compared with medical treatments for migraine," the
study team writes.
"For many years, a lot of patients with migraines were told the
disorder was all in their head, or they were depressed or stressed
out. It's important that as headache specialists we emphasize to our
patients that we are not sending them for psychotherapy when we
recommend behavioral migraine treatment," said Dr. Amaal Starling, a
neurologist at the Mayo Clinic in Phoenix, Arizona, who wasn't
involved in the study.
"We need to explain that behavioral techniques teach skills to help
manage migraines," Starling said in a telephone interview.
"These patients fall through the cracks," said Dr. Nauman Tariq,
director of the Johns Hopkins Headache Center in Baltimore,
Maryland. "They become a little defensive if we don't do a good job
of explaining why we want them to see a psychologist, but they are
an important and necessary part of the headache team," he noted.
"Behavioral therapy improves patients' quality of life. They
perceive less pain, miss less work and can enjoy their activities
again," said Tariq, who was not involved in the study.
SOURCE: https://bit.ly/2sLYaHu Pain Medicine, online June 5, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |
